Literature DB >> 21040992

The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.

Liang Zhao1, Qiuyan Wan, Yongqiang Zhou, Xia Deng, Congyin Xie, Shixiu Wu.   

Abstract

BACKGROUND AND
PURPOSE: Anatomic changing frequently occurred during fractionated radiotherapy. The aims of this study were to model the potential benefit of adaptive IMRT replanning during fractionated radiotherapy and its potential advantage over clinical outcome in patients with nasopharyngeal carcinoma.
MATERIALS AND METHODS: Thirty-three patients with repeat CT imaging and replanning were retrospectively analyzed. 66 case-matched control patients without replanning were identified by matching for AJCC stage, gender, and age. Hybrid IMRT plans were generated to evaluate the dosimetric changing. Mann-Whitney-Wilcoxon tests were used to evaluate the effect of replanning on volumetric and dosimetric outcomes within individuals. Kaplan-Meier estimators were used to estimate the survival function of patients with or without replanning.
RESULTS: The mean volume of the ipsilateral and contralateral parotid glands decreased during the treatment. The hybrid IMRT plans showed decreased doses to target volumes and increased doses to normal structures in replanning. The clinical outcome comparison indicated that the IMRT replanning improved the 3 years local progression-free survival for patients who had AJCC staged more than T(3) (T(3,4)N(x)) and ease the late effects for patients who had large lymph nodes (AJCC stage T(x)N(2,3)).
CONCLUSION: Repeat CT imaging and IMRT replanning were recommendatory for specific nasopharyngeal carcinoma patients. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21040992     DOI: 10.1016/j.radonc.2010.10.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  51 in total

1.  Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.

Authors:  Weidong Wang; Jinyi Lang
Journal:  Exp Ther Med       Date:  2012-05-30       Impact factor: 2.447

2.  Head and neck intensity modulated radiotherapy parotid glands: time of re-planning.

Authors:  Alba Fiorentino; Mariella Cozzolino; Rocchina Caivano; Piernicola Pedicini; Caterina Oliviero; Costanza Chiumento; Stefania Clemente; Vincenzo Fusco
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

Review 3.  Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician.

Authors:  Jolien Heukelom; Clifton David Fuller
Journal:  Semin Radiat Oncol       Date:  2019-07       Impact factor: 5.934

4.  Magnetic Resonance Imaging Volumetry of Primary Nasopharyngeal Cancer in Patients Treated with Induction Gemcitabine and Cisplatin Followed by Concurrent Cisplatin and Volumetric Modulated Arc Therapy.

Authors:  Joshua Giambattista; Nevin McVicar; Sarah Hamilton; Montgomery Martin; Benjamin Maas; Cheryl Ho; Jonn Wu; Eric Tran; John Hay; Eric Berthelet
Journal:  Cureus       Date:  2018-09-13

5.  Sustained improvement of quality of life for nasopharyngeal carcinoma treated by intensity modulated radiation therapy in long-term survivors.

Authors:  Tao Song; Ming Fang; Xue-Bang Zhang; Ping Zhang; Rui-Fei Xie; Shi-Xiu Wu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Adaptive Radiotherapy for Head Neck Cancer.

Authors:  Shrikant Balasaheb Mali
Journal:  J Maxillofac Oral Surg       Date:  2016-02-22

7.  The tumor shape changes of nasopharyngeal cancer during chemoradiotherapy: the estimated margin to cover the geometrical variation.

Authors:  Wenyong Tan; Jianzeng Ye; Ruilian Xu; Xianming Li; Wan He; Xiaohong Wang; Yanping Li; Desheng Hu
Journal:  Quant Imaging Med Surg       Date:  2016-04

8.  Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands.

Authors:  A Fiorentino; M Cozzolino; R Caivano; P Pedicini; C Chiumento; C Oliviero; S Clemente; V Fusco
Journal:  Clin Transl Oncol       Date:  2012-10-13       Impact factor: 3.405

9.  Adaptive Radiotherapy for Head and Neck Cancer.

Authors:  Murat Surucu; Karan K Shah; John C Roeske; Mehee Choi; William Small; Bahman Emami
Journal:  Technol Cancer Res Treat       Date:  2016-08-19

10.  Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: an "old" adaptive radiation therapy approach.

Authors:  Alessia Reali; Silvia Maria Anglesio; Gianluca Mortellaro; Simona Allis; Sara Bartoncini; Maria Grazia Ruo Redda; Francesca Arcadipane
Journal:  Radiol Med       Date:  2014-02-08       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.